Zhejiang Raygene Pharmaceuticals Co., Ltd
Zhejiang Raygene Pharmaceuticals Co., Ltd
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II/III Trial Comparing Transarterial Tirapazamine Embolization (TATE) With cTACE for Intermediate-stage Liver Cancer. | hepatocellular carcinoma | Recruiting | Phase 2 / Phase 3 | 2025-04-06 | NCT06844357 |